Evaluating the pharmacokinetics and bioavailability of Pterygota alata inflorescence based on HRMS study to determine the reservoirs of Ayurvedic components with an emphasis on their potential therapeutic use for diabetes mellitus
DOI:
https://doi.org/10.47552/ijam.v15iS1.5563Keywords:
Diabetes, Pterygota alata, HRMS, Hyperglycemia, Pharmacokinetic, BioavailabilityAbstract
Diabetes indeed requires a comprehensive approach, and dietary changes play a crucial role in managing the condition. While traditional methods like Ayurveda have been used for centuries to address various ailments, including diabetes. Pterygota alata, commonly known as the "winged seed" tree, has been explored for its potential antidiabetic properties in Ayurveda. Research into its efficacy and safety is ongoing, with some studies suggesting promising results. As with any herbal remedy, individuals with diabetes must consult healthcare professionals before incorporating them into their treatment regimen. While herbal products can complement conventional therapies, they should not replace them entirely. Additionally, potential interactions with other medications and individual variations in response should be carefully considered. Through UHPLC-Q-TOF-MS/MS system major antidiabetic component such as Agmatine, Migitol, Trigoneline, Betaine, Theophylline, Quercetin, Kaempferol, Isoliquiritigenin, Esculetin, Rutin, Ferulic acid, Eriodictyol, Naringenin, Luteolin, Salsonilon, Apigenin, Hesperitine, Carvone, Ursolic acid, Betulin, Lupeol, Eugenol.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.